Career Interview

Rachel Youjin Oh, MD, is a fourth year resident in the Medical Genetics and Genomics program at the University of Toronto and the Hospital for Sick Children.

Inside HGG Advances: A Chat with Rachel Oh

Posted By: HGG Advances HGGA: What motivated you to start working on this project? RO: Accurate variant interpretation is essential to both genome diagnostics and screening in medical genetics. Canonical splice site variants (CSSVs) are considered “null variants” (in the same category as nonsense, frameshift, initiation codon, single or multi-exon deletion variants) in a gene... Read More

Diptavo Dutta, PhD is an investigator in the Division of Cancer Epidemiology & Genetics at the National Cancer Institute.

Inside HGG Advances: A Chat with Diptavo Dutta

Posted By: HGG Advances HGGA: What motivated you to start working on this project? DD: The scientific motivation of this work was to investigate, for diseases, whether there are tissues beyond the obvious candidates where genes might manifest associations, and if so, can we interpret such findings from an etiologic viewpoint. The statistical method is... Read More

Inside HGG Advances: A Chat with Tianyu Zhang

Posted By: HGG Advances HGGA: What motivated you to start working on this project? TZ: As a researcher with biostatistics training, I feel it is crucial to get my hands on real-world data to validate the efficiency of many methods that people develop on paper or whiteboards. My advisor kindly offered me this opportunity! HGGA:... Read More

Member Spotlight: A Chat with Ileana Delia Sabau, MD

Member Spotlight: A Chat with Ileana Delia Sabau, MD

The ASHG membership team recently sat down with Ileana Delia Sabau, MD an MD Specialist in Medical Genetics at Synevo Romania. As a part of the ESHG-Y, the European Society of Human Genetics’ Young Geneticists Committee, Dr. Sabau is passionate about engaging the next generation and shares her work in the field as well as... Read More

Cassie Spracklen, PhD is an assistant professor in the Department of Biostatistics and Epidemiology at the University of Massachusetts-Amherst.

Inside HGG Advances: A Chat with Cassie Spracklen

Posted By: HGG Advances HGGA: What motivated you to start working on this project? CS: In order to move from genome-wide associated loci toward potentially effective clinical and therapeutic targets, we need to identify which target/effector gene(s) the associate variants are being modulated. There are multiple methods that currently exist that can be used to... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy